Q-LINEA AB
Stock
Stock
ISIN: SE0025420714
Ticker: QLINEA
SE0025420714
QLINEA
Price
Price
CHART BY
Frequently asked questions
What is Q-LINEA AB's market capitalization?
The market capitalization of Q-LINEA AB is $37.86M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Q-LINEA AB?
Q-LINEA AB's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$14.92. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Q-LINEA AB's stock?
Currently, 1 analysts cover Q-LINEA AB's stock, with a consensus target price of $8.265. Analyst ratings provide insights into the stock's expected performance.
What is Q-LINEA AB's revenue over the trailing twelve months?
Over the trailing twelve months, Q-LINEA AB reported a revenue of $567.29K.
What is the EBITDA for Q-LINEA AB?
Q-LINEA AB's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$16.59M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Q-LINEA AB?
Q-LINEA AB has a free cash flow of -$18.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Q-LINEA AB have, and what sector and industry does it belong to?
Q-LINEA AB employs approximately 94 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Q-LINEA AB's shares?
The free float of Q-LINEA AB is 3.81M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $37.86M
- EPS (TTM)
- -$14.92
- Free Float
- 3.81M
- Revenue (TTM)
- $567.29K
- EBITDA (TTM)
- -$16.59M
- Free Cashflow (TTM)
- -$18.54M
Pricing
- 1D span
- $6.068$6.359
- 52W span
- $3.016$434.72
Analyst Ratings
The price target is $8.265 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Q-linea AB operates as a holding company. The firm engages in the development of inventive systems for in vitro diagnostics for infectious diseases. Its products include ASTar, ASTrID and Data. The company was founded by Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, Jan Grawe and Johan Stenberg in April 2008 and is headquartered in Uppsala, Sweden.
- Employees
- 94
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0025420714
- Primary Ticker
- QLINEA
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet